Stock BNGO BIONANO GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Real-time Estimate Cboe BZX
Other stock markets
 03:53:55 2024-07-09 pm EDT 		5-day change 1st Jan Change
0.622 USD +12.31% Intraday chart for Bionano Genomics, Inc. +7.68% -67.51%
Jul. 08 Bionano Genomics Raises $10 Million From Direct Offering MT
Jul. 05 Sector Update: Health Care Stocks Advance Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
AQ
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
AQ
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
AQ
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
AQ
Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow
AQ
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
AQ
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy
AQ
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
AQ
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
AQ
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
AQ
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
AQ
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
AQ
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
AQ
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
AQ
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
AQ
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
AQ
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
AQ
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting
AQ
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance
AQ
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. News Bionano Genomics, Inc.
  5. Press Releases